CMCT vs DEA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

CMCT

31.0
AI Score
VS
DEA Wins

DEA

38.1
AI Score

Investment Advisor Scores

CMCT

31score
Recommendation
SELL

DEA

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CMCT DEA Winner
Revenue 59.10M 33.86M CMCT
Net Income -18.20M 942,000 DEA
Net Margin -30.8% 2.8% DEA
ROE -7.4% 0.1% DEA
ROA -2.3% 0.1% DEA
Total Assets 782.94M 1.37B DEA
Cash 12.77M 6.55M CMCT
Debt/Equity 2.03 0.82 DEA

Relative Price Performance (Last 90 Days)

CMCT 1M: +60.8% · 3M: +60.8% DEA 1M: -5.2% · 3M: -11.9%

Current Technical Phase

CMCT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.7% over 20 days), RSI 52

RSI (14): 51.9 · Price: $4.10

DEA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.8%), weak momentum, RSI 38

RSI (14): 38.2 · Price: $22.10

Fundamentals Snapshot

Metric CMCT DEA
Market Cap — —
Forward P/E -0.5 69.1
Trailing P/E — 116.7
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.4% 0.7%
Operating Margin 0.0% 0.3%
EPS -2770.30 0.19
Dividend Yield — 0.08%

Frequently Asked Questions

Based on our detailed analysis, DEA is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.